StockMarketWire.com - Barclays Capital today reaffirms its overweight investment rating on Synthomer [LON:SYNT] and raised its price target to 560p (from 525p).

Story provided by StockMarketWire.com

Broker Forecasts data provided by www.sharesmagazine.co.uk